Department of Spine Surgery, The Third Xiangya Hospital of Central South University, No. 138, Tongzipo Road, Changsha, Hunan, People's Republic of China.
Department of Spine Surgery, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
J Physiol Biochem. 2020 May;76(2):279-290. doi: 10.1007/s13105-020-00730-8. Epub 2020 Feb 25.
Osteosarcoma (OS) is closely related to the dysregulation of various intracellular signaling pathways, especially the PI3K/Akt signaling pathway. Reportedly, HSP90 was responsible for phospho-Akt stabilization, and both AKT1 and HSP90 were upregulated within osteosarcoma. Herein, we demonstrated that AKT1 and HSP90 mRNA and protein expression were upregulated within osteosarcoma tissues and cells; AKT1 knockdown significantly inhibited OS cell viability. HSP90 knockdown suppressed the phosphorylation of AKT1, decreased ki-67 and Vimentin protein levels, enhanced p21 and E-cadherin protein levels, and inhibited OS cell proliferation and migration; AKT1 overexpression exerted opposing effects and significantly attenuated the effects of HSP90 knockdown. miR-485-5p targeted AKT1 and HSP90 3'-UTR to inhibit AKT1 and HSP90 expression. miR-485-5p overexpression dramatically reduced AKT1, HSP90, and ki-67 proteins, increased E-cadherin protein levels, and inhibited OS cell proliferation and migration. In conclusion, HSP90 knockdown blocked the phosphorylation of AKT1 suppressing the proliferation and migration capacity of OS cells via the PI3K/AKT pathway; miR-485-5p binds to HSP90 and AKT1 in their 3'-UTR to inhibit HSP90 and AKT1 expression, therefore exerting a tumor suppressor function within osteosarcoma.
骨肉瘤(OS)与各种细胞内信号通路的失调密切相关,尤其是 PI3K/Akt 信号通路。据报道,HSP90 负责磷酸化 Akt 的稳定,骨肉瘤中 AKT1 和 HSP90 均上调。在此,我们证明骨肉瘤组织和细胞中 AKT1 和 HSP90 的 mRNA 和蛋白表达上调;AKT1 敲低显著抑制 OS 细胞活力。HSP90 敲低抑制 AKT1 的磷酸化,降低 ki-67 和波形蛋白蛋白水平,增加 p21 和 E-钙黏蛋白蛋白水平,并抑制 OS 细胞增殖和迁移;AKT1 过表达则产生相反的效果,并显著减弱 HSP90 敲低的作用。miR-485-5p 靶向 AKT1 和 HSP90 的 3'-UTR 以抑制 AKT1 和 HSP90 的表达。miR-485-5p 过表达显著降低 AKT1、HSP90 和 ki-67 蛋白水平,增加 E-钙黏蛋白蛋白水平,并抑制 OS 细胞增殖和迁移。总之,HSP90 敲低通过 PI3K/AKT 通路抑制 AKT1 的磷酸化,从而抑制 OS 细胞的增殖和迁移能力;miR-485-5p 结合 HSP90 和 AKT1 的 3'-UTR 以抑制 HSP90 和 AKT1 的表达,因此在骨肉瘤中发挥肿瘤抑制功能。